Advertisement

Topics

Innodia Company Profile

08:01 EST 14th December 2018 | BioPortfolio

Founded in 2002, Innodia is located in Montreal, Canada and presently employs over 30 individuals, including 24 scientists.
In September 2003, Innodia completed a US$10 million Series A financing. Innodia’s shareholders include: Picchio Pharma, HBM BioVentures Ltd., CDP Capital - Technology Ventures, Business Development Bank of Canada, Neurochem and private investors. In addition, Innodia secured a US$10 million venture debt under the Québec BioLevier program, matching its Series A financing. This financial support provides Innodia with the necessary resources to advance its antidiabetic product pipeline well into clinical development and substantially reduces the Company's business risk.
In the last 12 months, Innodia has brought ID 1101, its lead compound, into a Phase Ib clinical trial; initiated clinical trials with ID 1135; obtained in vivo proof of concept for ID 1738, a potent gluco-related insulin secretagogue and advanced its anti-amyloid program well into in vivo proof-of-concept determination.
During this period, Innodia also structured several collaborative efforts with world-renowned diabetes research centres, including the newly created Montreal Diabetes Research Center, Laval University, the Universtiy of Montreal Hospital Centre (CHUM), University of Toronto, University of Montpellier (France), Louis-Pasteur University (France), Bar-Ilan University (Israel) and Centre national de la recherche scientifique (CNRS), the leading French research institute.
With its vast experience in the discovery and development of diabetes drugs, its large network of collaborations and its strategic investor base, Innodia is uniquely positioned to help advance publicly funded research in Canada in the field of type 2 diabetes, leading to the development of new classes of antidiabetic agents.

Location

500 Cartier Blvd. West Suite 132
Laval
Quebec
H7V 5B7
Canada

Contact

Phone: 1.450.781.8818
Fax: 1.450.781.8819
Email: info@innodia-inc.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Innodia

Founded in 2002, Innodia is located in Montreal, Canada and presently employs over 30 individuals, including 24 scientists.In September 2003, Innodia completed a US$10 million Series A financing. Inno...

More Information about "Innodia" on BioPortfolio

We have published hundreds of Innodia news stories on BioPortfolio along with dozens of Innodia Clinical Trials and PubMed Articles about Innodia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innodia Companies in our database. You can also find out about relevant Innodia Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record